The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma |
| |
Authors: | Lv Lin Pan Ke Li Xiao-dong She Ke-lin Zhao Jing-jing Wang Wei Chen Ju-gao Chen Yi-bin Yun Jing-ping Xia Jian-chuan |
| |
Institution: | State Key Laboratory of Oncology in Southern China and Department of Experimental Research, Cancer Center, Sun Yat-sen University, Guangzhou, People's Republic of China. |
| |
Abstract: | BackgroundThe role of IL-17 producing cells in tumors is controversial. In the present study, we investigated the prognostic value of measuring tumor-infiltrating IL-17 producing cell levels in human esophageal squamous cell carcinoma (ESCC).Methodology/Principal FindingsImmunohistochemical staining was performed to investigate the levels of IL-17+ tumor infiltrating lymphocytes (TILs), as well as CD8+ cytotoxic T lymphocytes (CTLs) and CD57+ natural killer (NK) cells from 181 ESCC patients. The prognostic value of measuring the densities of IL-17+TILs and the correlation with CTLs and NK was evaluated. IL-17 producing cells were detected in esophageal squamous cell carcinoma tissues. The IL-17 producing cells were major CD4 positive, but Foxp3 negative. The median level of IL-17+TILs was 3.90 cells/high power microscopic field (HPF). The density of IL-17 producing cells correlated negatively with T stage (P?=?0.042). The higher densities of tumor infiltrating IL-17+ lymphocytes were associated with better overall survival (P?=?0.031). Furthermore, we found that there were positive correlations between levels of IL-17 producing cells and the densities of CD8+cells, as well as CD57+cells (r?=?0.198, P?=?0.008 for CD8+ cells and r?=?0.261, P<0.001 for CD57+ cells, respectively). The prognosis analysis also showed that the higher levels of CD8+ CTLs and CD57+ NK cells correlated with better overall survival of ESCC patients.ConclusionsOur study suggests that tumor infiltrating IL-17 producing cells in ESCC patients may have protective roles in the tumor microenvironment and may be treated as a prognostic marker for ESCC patients. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|